Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1995 Dec;39(12):2656–2660. doi: 10.1128/aac.39.12.2656

Mutacin II, a bactericidal antibiotic from Streptococcus mutans.

M L Chikindas 1, J Novák 1, A J Driessen 1, W N Konings 1, K M Schilling 1, P W Caufield 1
PMCID: PMC163007  PMID: 8592997

Abstract

Mutacin II is an antibiotic that is produced by group II Streptococcus mutans. It inhibits the growth of other streptococci as well as many other gram-positive microorganisms by a hitherto unknown mechanism. Mutacin II possess bactericidal activity against susceptible cells. It transiently depolarizes the transmembrane electrical potential (delta psi) and the transmembrane pH gradient (delta pH) and partially inhibits amino acid transport. However, it rapidly depletes the intracellular ATP pool in glucose-energized cells and prevents the generation of ATP. It is concluded that mutacin II does not belong to the group of pore-forming antibiotics (type A) or to the type B antibiotics, which inhibit phospholipases or interfere with peptidoglycan biosynthesis. Mutacin II acts by inhibiting essential enzyme functions at the level of metabolic energy generation, an activity that has not yet been classified for antibiotics.

Full Text

The Full Text of this article is available as a PDF (229.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chikindas M. L., García-Garcerá M. J., Driessen A. J., Ledeboer A. M., Nissen-Meyer J., Nes I. F., Abee T., Konings W. N., Venema G. Pediocin PA-1, a bacteriocin from Pediococcus acidilactici PAC1.0, forms hydrophilic pores in the cytoplasmic membrane of target cells. Appl Environ Microbiol. 1993 Nov;59(11):3577–3584. doi: 10.1128/aem.59.11.3577-3584.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chopin A., Chopin M. C., Moillo-Batt A., Langella P. Two plasmid-determined restriction and modification systems in Streptococcus lactis. Plasmid. 1984 May;11(3):260–263. doi: 10.1016/0147-619x(84)90033-7. [DOI] [PubMed] [Google Scholar]
  3. Driessen A. J., Kodde J., de Jong S., Konings W. N. Neutral amino acid transport by membrane vesicles of Streptococcus cremoris is subject to regulation by internal pH. J Bacteriol. 1987 Jun;169(6):2748–2754. doi: 10.1128/jb.169.6.2748-2754.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Driessen A. J., van den Hooven H. W., Kuiper W., van de Kamp M., Sahl H. G., Konings R. N., Konings W. N. Mechanistic studies of lantibiotic-induced permeabilization of phospholipid vesicles. Biochemistry. 1995 Feb 7;34(5):1606–1614. doi: 10.1021/bi00005a017. [DOI] [PubMed] [Google Scholar]
  5. Hamada S., Ooshima T. Production and properties of bacteriocins (mutacins) from Streptococcus mutans. Arch Oral Biol. 1975 Oct;20(10):641–648. doi: 10.1016/0003-9969(75)90131-4. [DOI] [PubMed] [Google Scholar]
  6. Henderson J. T., Chopko A. L., van Wassenaar P. D. Purification and primary structure of pediocin PA-1 produced by Pediococcus acidilactici PAC-1.0. Arch Biochem Biophys. 1992 May 15;295(1):5–12. doi: 10.1016/0003-9861(92)90480-k. [DOI] [PubMed] [Google Scholar]
  7. Howell T. H., Fiorellini J. P., Blackburn P., Projan S. J., de la Harpe J., Williams R. C. The effect of a mouthrinse based on nisin, a bacteriocin, on developing plaque and gingivitis in beagle dogs. J Clin Periodontol. 1993 May;20(5):335–339. doi: 10.1111/j.1600-051x.1993.tb00369.x. [DOI] [PubMed] [Google Scholar]
  8. Kelstrup J., Gibbons R. J. Bacteriocins from human and rodent streptococci. Arch Oral Biol. 1969 Mar;14(3):251–258. doi: 10.1016/0003-9969(69)90227-1. [DOI] [PubMed] [Google Scholar]
  9. Konings W. N., Poolman B., Driessen A. J. Bioenergetics and solute transport in lactococci. Crit Rev Microbiol. 1989;16(6):419–476. doi: 10.3109/10408418909104474. [DOI] [PubMed] [Google Scholar]
  10. Molenaar D., Abee T., Konings W. N. Continuous measurement of the cytoplasmic pH in Lactococcus lactis with a fluorescent pH indicator. Biochim Biophys Acta. 1991 Nov 14;1115(1):75–83. doi: 10.1016/0304-4165(91)90014-8. [DOI] [PubMed] [Google Scholar]
  11. Molenaar D., Bolhuis H., Abee T., Poolman B., Konings W. N. The efflux of a fluorescent probe is catalyzed by an ATP-driven extrusion system in Lactococcus lactis. J Bacteriol. 1992 May;174(10):3118–3124. doi: 10.1128/jb.174.10.3118-3124.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Novák J., Caufield P. W., Miller E. J. Isolation and biochemical characterization of a novel lantibiotic mutacin from Streptococcus mutans. J Bacteriol. 1994 Jul;176(14):4316–4320. doi: 10.1128/jb.176.14.4316-4320.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Poolman B., Hellingwerf K. J., Konings W. N. Regulation of the glutamate-glutamine transport system by intracellular pH in Streptococcus lactis. J Bacteriol. 1987 May;169(5):2272–2276. doi: 10.1128/jb.169.5.2272-2276.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Poolman B., Smid E. J., Veldkamp H., Konings W. N. Bioenergetic consequences of lactose starvation for continuously cultured Streptococcus cremoris. J Bacteriol. 1987 Apr;169(4):1460–1468. doi: 10.1128/jb.169.4.1460-1468.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Russell C., Tagg J. R. Role of bacteriocin during plaque formation by Streptococcus salivarius and Streptococcus sanguis on a tooth in an artificial mouth. J Appl Bacteriol. 1981 Apr;50(2):305–313. doi: 10.1111/j.1365-2672.1981.tb00895.x. [DOI] [PubMed] [Google Scholar]
  16. Sahl H. G., Jack R. W., Bierbaum G. Biosynthesis and biological activities of lantibiotics with unique post-translational modifications. Eur J Biochem. 1995 Jun 15;230(3):827–853. doi: 10.1111/j.1432-1033.1995.tb20627.x. [DOI] [PubMed] [Google Scholar]
  17. Sahl H. G., Kordel M., Benz R. Voltage-dependent depolarization of bacterial membranes and artificial lipid bilayers by the peptide antibiotic nisin. Arch Microbiol. 1987;149(2):120–124. doi: 10.1007/BF00425076. [DOI] [PubMed] [Google Scholar]
  18. Schüller F., Benz R., Sahl H. G. The peptide antibiotic subtilin acts by formation of voltage-dependent multi-state pores in bacterial and artificial membranes. Eur J Biochem. 1989 Jun 1;182(1):181–186. doi: 10.1111/j.1432-1033.1989.tb14815.x. [DOI] [PubMed] [Google Scholar]
  19. Shinbo T., Kamo N., Kurihara K., Kobatake Y. A PVC-based electrode sensitive to DDA+ as a device for monitoring the membrane potential in biological systems. Arch Biochem Biophys. 1978 Apr 30;187(2):414–422. doi: 10.1016/0003-9861(78)90052-8. [DOI] [PubMed] [Google Scholar]
  20. Tagg J. R. Studies of "BLIS-ful" oral bacteria. N Z Dent J. 1991 Jan;87(387):14–16. [PubMed] [Google Scholar]
  21. Thompson J. Characteristics and energy requirements of an alpha-aminoisobutyric acid transport system in Streptococcus lactis. J Bacteriol. 1976 Aug;127(2):719–730. doi: 10.1128/jb.127.2.719-730.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES